Skip to main content

Table 3 Number (percent) of COPD exacerbations per patient by treatment group for subjects with baseline CRP ≥ 4 mg/L and < 4 mg/L

From: Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels

COPD exacerbations per patient

 

0 or 1

 ≤ 2

Baseline COPD ≥ 4 mg/L

Placebo N = 17

11 (65)

6 (35)

Remestemcel-L N = 12

10 (83)

2 (17)

Baseline COPD < 4 mg/L

Placebo N = 15

13 (87)

2 (13)

Remestemcel-L N = 18

12 (67)

6 (33)

  1. COPD chronic obstructive lung disease, CRP C-reactive protein